These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33515519)

  • 21. Prevention of pneumococcal disease: an update on the Belgian Consensus Report.
    Peleman RA; Peetermans WE; Van Laethem Y; Bachez PG; Vanatoru J; Van Wassenhove K; Struelens MJ; Verhaegen JL
    Acta Clin Belg; 1999 Dec; 54(6):321-7. PubMed ID: 10686704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children.
    von Kries R; Hermann M; Hachmeister A; Siedler A; Schmitt HJ; Al-Lahham A; Reinert RR
    Pediatr Infect Dis J; 2002 Nov; 21(11):1017-23. PubMed ID: 12442022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
    Zangeneh TT; Baracco G; Al-Tawfiq JA
    Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of pneumococcal disease in children. Pneumococcal conjugate vaccines: their use globally could have a major impact on public health.
    Kyaw MH; Jones IG; Campbell H
    Acta Paediatr; 2001 May; 90(5):473-6. PubMed ID: 11430703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of invasive pneumococcal disease in children 3 to 36 months of age at a tertiary care pediatric center 2 years after licensure of the pneumococcal conjugate vaccine.
    Lin PL; Michaels MG; Janosky J; Ortenzo M; Wald ER; Mason EO
    Pediatrics; 2003 Apr; 111(4 Pt 1):896-9. PubMed ID: 12671130
    [No Abstract]   [Full Text] [Related]  

  • 26. Vaccination, underlying comorbidities, and risk of invasive pneumococcal disease.
    Yildirim I; Shea KM; Little BA; Silverio AL; Pelton SI;
    Pediatrics; 2015 Mar; 135(3):495-503. PubMed ID: 25647674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The conjugate vaccine and invasive pneumococcal disease.
    Konradsen HB; Nokleby H
    N Engl J Med; 2003 Aug; 349(7):714-6; author reply 714-6. PubMed ID: 12921091
    [No Abstract]   [Full Text] [Related]  

  • 28. Pneumococcal vaccines and flu preparedness.
    Klugman KP; Madhi SA
    Science; 2007 Apr; 316(5821):49-50. PubMed ID: 17412937
    [No Abstract]   [Full Text] [Related]  

  • 29. Pneumococcal conjugate vaccines in different settings - Authors' reply.
    Hanage WP; Lewnard JA
    Lancet Infect Dis; 2019 Dec; 19(12):1284. PubMed ID: 31782391
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pneumococcal conjugate vaccine in children and the emergence of serotype 19A].
    Lepetic A; De Antonio R; Nieto G J
    Rev Chilena Infectol; 2016 Dec; 33(6):707-709. PubMed ID: 28146201
    [No Abstract]   [Full Text] [Related]  

  • 31. From global to regional: the importance of pneumococcal disease in Latin America.
    de Quadros CA
    Vaccine; 2009 Aug; 27 Suppl 3():C29-32. PubMed ID: 19540025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ; McIntosh ED; Reinert RR
    Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach?
    Desmet S; Verhaegen J; Van Ranst M; Peetermans W; Lagrou K
    Lancet Infect Dis; 2018 Aug; 18(8):830-831. PubMed ID: 30001857
    [No Abstract]   [Full Text] [Related]  

  • 34. Potential impact of conjugate pneumococcal vaccines on pediatric pneumococcal diseases.
    O'Brien KL; Santosham M
    Am J Epidemiol; 2004 Apr; 159(7):634-44. PubMed ID: 15033641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invasive pneumococcal disease in Fiji: clinical syndromes, epidemiology, and the potential impact of pneumococcal conjugate vaccine.
    Russell FM; Carapetis JR; Tikoduadua L; Paeds D; Chandra R; Seduadua A; Satzke C; Pryor J; Buadromo E; Waqatakirewa L; Mulholland EK
    Pediatr Infect Dis J; 2010 Sep; 29(9):870-2. PubMed ID: 20622710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of invasive pneumococcal and Haemophilus influenzae diseases in Northwestern Ontario, Canada, 2010-2015.
    Eton V; Schroeter A; Kelly L; Kirlew M; Tsang RSW; Ulanova M
    Int J Infect Dis; 2017 Dec; 65():27-33. PubMed ID: 28951105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Conjugate vaccines changed the epidemiology of infection].
    Ecker-Schlipf B
    Med Monatsschr Pharm; 2006 Aug; 29(8):307-8. PubMed ID: 16927601
    [No Abstract]   [Full Text] [Related]  

  • 38. Pneumococcal vaccination for Indian children.
    Levine OS; Cherian T
    Indian Pediatr; 2007 Jul; 44(7):491-6. PubMed ID: 17684301
    [No Abstract]   [Full Text] [Related]  

  • 39. Pneumococcal vaccines for children: a global public health priority.
    Pittet LF; Posfay-Barbe KM
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():25-36. PubMed ID: 22862432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Rationale for Change: An Increase in Invasive Pneumococcal Disease in Fully Vaccinated Children.
    Blyth CC; Jayasinghe S; Andrews RM
    Clin Infect Dis; 2020 Feb; 70(4):680-683. PubMed ID: 31209491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.